Investor Spotlight: Connecticut Innovations

Let’s get more solutions to patients. The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC’s, Angels and other investment entities.

On September 26th, Amanda Hayward from Connecticut Innovations will present an overview of the fund, it’s investment strategy, primary areas of interest, and a few investment case studies. Following the presentation, they will meet 1-on-1 with companies that have been accepted after applying online.

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due September 9, 2019. Apply Here.

About Connecticut Innovations

CI is Connecticut’s strategic venture capital arm and is the leading source of financing and ongoing support for innovative, growing companies. By offering equity investments, strategic guidance and introductions to valuable partners, they enable promising businesses to thrive.

Connecticut Innovations manages a $200 million life sciences focused fund (CBIF), making equity and debt investments in early stage companies across the bioscience spectrum, including therapeutics, diagnostics, medtech and healthcare IT . CI’s goal is to grow the life science ecosystem within the state, as well as to speed commercializable bioscience breakthroughs to market.

To be considered for a 1-on-1 meeting complete the information required here. Applications due by September 9, 2019.